☆ 4.7 Review

The functional and clinical roles of liquid biopsy in patient-derived models

JOURNAL OF HEMATOLOGY & ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

Circulating tumor nucleic acids: biology, release mechanisms, and clinical relevance

Pavel Stejskal et al.

Summary: Despite advances, cancer remains a leading cause of death worldwide. Liquid biopsies allow for real-time, noninvasive monitoring of tumor burden through the detection of ctNAs in the blood. Understanding the biology and release mechanisms of ctDNA and ctRNA can improve cancer patient outcomes in personalized medicine.

MOLECULAR CANCER (2023)

Add to Collection

Article Oncology

Extracellular vesicles as a liquid biopsy for melanoma: Are we there yet?

Lidia B. Medhin et al.

Summary: Melanoma, as an aggressive form of skin cancer, has limited treatment options and requires biomarkers to guide treatment decisions. The analysis of peripheral blood samples, particularly extracellular vesicles (EVs), has shown promise in overcoming the limitations of tissue sampling for cancer dissemination, immune modulation, and drug resistance. EVs have potential as biomarkers for melanoma diagnosis, prognosis, therapy response prediction, and drug resistance, especially in predicting therapeutic response to immune checkpoint inhibition. However, further research and strong clinical validation are needed to fully realize the potential of EV analysis for clinical decision-making.

SEMINARS IN CANCER BIOLOGY (2023)

Add to Collection

Article Multidisciplinary Sciences

DNA methylation analysis explores the molecular basis of plasma cell-free DNA fragmentation

Yunyun An et al.

Summary: The authors used orientation-aware fragmentation analysis to identify DNA methylation as a regulator of nuclease function. They found that low-level DNA methylation can increase nucleosome accessibility and alter the cutting activities of nucleases during DNA fragmentation, leading to variation in cutting sites and size distribution of cell-free DNA (cfDNA). They also developed a cfDNA ending preference-based metric for cancer diagnosis, which has been validated by multiple pan-cancer datasets.

NATURE COMMUNICATIONS (2023)

Add to Collection

Article Chemistry, Multidisciplinary

All-in-One Nanowire Assay System for Capture and Analysis of Extracellular Vesicles from an ex Vivo Brain Tumor Model

Kunanon Chattrairat et al.

Summary: Extracellular vesicles (EVs) have great potential as biomarkers for early cancer diagnosis. The membrane protein expression ratio of CD31/CD63 was found to be significantly higher in tumor organoid-derived EVs and urine samples from glioblastoma patients compared to noncancer subjects, indicating the potential of the nanowire assay system for EV-mediated tumor-microenvironment crosstalk analysis.

ACS NANO (2023)

Add to Collection

Article Oncology

An In Vivo CRISPR Screen Identifies Stepwise Genetic Dependencies of Metastatic Progression

Manuel C. Scheidmann et al.

Summary: This study identified specific genetic dependencies for each step of the metastatic process in breast cancer using a newly derived CTC xenograft model and a loss-of-function CRISPR screen. The findings provide insights into the biology of metastasis and potential targeted treatment approaches for metastatic breast cancer.

CANCER RESEARCH (2022)

Add to Collection

Review Oncology

Circulating Tumor DNA Minimal Residual Disease Detection of Non-Small-Cell Lung Cancer Treated With Curative Intent

Bruna Pellini et al.

Summary: Circulating tumor DNA minimal residual disease is a powerful biomarker with the potential to improve survival outcomes for non-small-cell lung cancer. Although the current studies are limited in size, largely retrospective, and without thorough prospective clinical validation, the detection of ctDNA minimal residual disease has shown good sensitivity and specificity at the first post-treatment timepoint, and improved performance in surveillance.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Review Multidisciplinary Sciences

Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges

Enrique Sanz-Garcia et al.

Summary: Circulating tumor DNA (ctDNA) is a widely applicable biomarker in cancer management. Changes in ctDNA levels over time, known as ctDNA kinetics, have the potential to serve as early indicators of therapeutic efficacy and allow for treatment adaptation. However, ctDNA kinetics are complex and heterogeneous, influenced by various factors.

SCIENCE ADVANCES (2022)

Add to Collection

Review Engineering, Biomedical

Limitations and opportunities of technologies for the analysis of cell-free DNA in cancer diagnostics

Ping Song et al.

Summary: This Review discusses the challenges and opportunities of technologies for the analysis of cell-free DNA for cancer diagnosis. It highlights the potential of cfDNA as biomarkers for guiding therapy, monitoring drug resistance, and early detection of cancers. However, the low concentrations and fragmented nature of cfDNA present challenges for clinical diagnostic applications. The Review describes state-of-the-art technologies and highlights the need to address biological and technical challenges to improve cancer diagnostics and patient care.

NATURE BIOMEDICAL ENGINEERING (2022)

Add to Collection

Article Hematology

Targeting CD70 in cutaneous T-cell lymphoma using an antibody-drug conjugate in patient-derived xenograft models

Chi-Heng Wu et al.

Summary: CD70 is highly expressed in T-cell lymphomas, especially in CTCL. SGN-CD70A, a CD70-directed antibody-drug conjugate, inhibits cell growth and induces apoptosis in CD70-expressing CTCL cells, and multiple dosing of SGN-CD70A can completely eradicate established tumors.

BLOOD ADVANCES (2022)

Add to Collection

Article Oncology

In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types

M. D. Matossian et al.

Summary: This study introduces an innovative translational model system to study cell-matrix interactions in rare cancer types, using higher passage PDX tissue.

CLINICAL & TRANSLATIONAL ONCOLOGY (2022)

Add to Collection

Article Oncology

Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma

Yuan-Hung Wu et al.

Summary: This study successfully expanded circulating tumor cells (CTCs) from liquid biopsies of patients with pancreatic ductal adenocarcinoma (PDAC) using a laboratory-developed biomimetic cell culture system. Drug sensitivity profiles of CTC-derived organoid cultures correlated meaningfully with treatment response. This approach has the potential to be a predictive method for treatment response in PDAC patients.

EUROPEAN JOURNAL OF CANCER (2022)

Add to Collection

Article Biochemistry & Molecular Biology

CD44 Expression Intensity Marks Colorectal Cancer Cell Subpopulations with Different Extracellular Vesicle Release Capacity

Andrea Kelemen et al.

Summary: Extracellular vesicles (EV) are released by almost all cells and play a role in transporting important molecules to target cells. In this study, CRC patient-derived organoids were used to show that CD44(high) cells release more EVs, which can induce stronger proliferation and activation of colon fibroblasts.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses

Kanve N. Suvilesh et al.

Summary: By establishing stable CDX models from CTCs isolated from ptPDX mice, researchers identified distinct drug responses and cell heterogeneities in CDX tumors, offering potential personalized strategies against micrometastases in non-metastatic NSCLC patients.

MOLECULAR CANCER (2022)

Add to Collection

Article Multidisciplinary Sciences

Proteomic analysis distinguishes extracellular vesicles produced by cancerous versus healthy pancreatic organoids

Abigail C. Buenafe et al.

Summary: Extracellular vesicles (EVs) derived from pancreatic ductal adenocarcinoma (PDAC) and healthy organoids exhibit distinct protein profiles related to vesicular transport, tumorigenesis, and cellular homeostasis, respectively. Tumor-promoting candidates LAMA5, SDCBP, and TENA were found to be consistently upregulated in PDAC EVs, highlighting their potential as biomarkers for monitoring disease progression. Disease-associated changes in EV protein profiles provide insights into alterations in cellular programming with disease progression.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Medicine, Research & Experimental

Targeting genome integrity dysfunctions impedes metastatic potency in non-small cell lung cancer circulating tumor cell- derived explants

Tala Tayoun et al.

Summary: DNA damage and genomic instability contribute to non-small cell lung cancer, and CDX models derived from CTCs provide insights into the mechanisms of CTC metastasis and potential therapeutics.

JCI INSIGHT (2022)

Add to Collection

Article Oncology

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group

J. Pascual et al.

Summary: Circulating tumour DNA (ctDNA) assays conducted on plasma are proving to be valuable tools for identifying actionable mutations in patients with advanced cancer and for detecting molecular residual disease or relapse in early-stage cancer. However, tissue-based testing is still preferred due to the limitations of ctDNA assays.

ANNALS OF ONCOLOGY (2022)

Add to Collection

Article Medicine, Research & Experimental

Longitudinal monitoring of disease burden and response using ctDNA from dried blood spots in xenograft models

Carolin M. Sauer et al.

Summary: This study describes a method for detecting and monitoring ctDNA from minute volumes of blood in PDX mice. By using shallow WGS of dried blood spots, a xenograft Tumour Fraction (xTF) metric was developed and applied in preclinical research to quantify disease burden, monitor treatment response, and predict disease outcome. Furthermore, this method can also detect gene-specific copy number changes and examine the copy number landscape.

EMBO MOLECULAR MEDICINE (2022)

Add to Collection

Article Cell Biology

A human kidney and liver organoid-based multi-organ-on-a-chip model to study the therapeutic effects and biodistribution of mesenchymal stromal cell-derived extracellular vesicles

Vivian V. T. Nguyen et al.

Summary: This study used an in vitro multi-organ-on-a-chip model to investigate the effects of MSC-derived sEVs on kidney and liver organoids. The results showed that sEVs stimulated recovery of injured renal epithelium and accumulated in both injured kidney cells and intact liver organoids. This research method provides insights into the mechanism of action and potential side effects of sEVs.

JOURNAL OF EXTRACELLULAR VESICLES (2022)

Add to Collection

Article Dermatology

Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDAC

Chi-Heng Wu et al.

Summary: Cutaneous T-cell lymphoma is a type of non-Hodgkin lymphoma that starts in the skin and spreads systemically, with limited treatment options. Researchers identified PI3K inhibitor BKM120 as potentially effective in the disease through high-throughput screening and patient-derived xenograft mouse models, and demonstrated the importance of PI3K-delta in tumor proliferation.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)

Add to Collection

Article Oncology

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Carl M. Gay et al.

Summary: Despite the heterogeneity of small cell lung cancer (SCLC), four subtypes have been identified based on tumor expression data, each showing different responses to treatment. SCLC-I subtype benefits the most from immunotherapy, while other subtypes have vulnerabilities to different inhibitors. Matching tumor subtype to therapy and manipulating subtype switching during treatment may enhance response depth and duration for SCLC patients.

CANCER CELL (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technology

Aniko Zeold et al.

Summary: Extracellular vesicles (EV) are considered a potential diagnostic tool for pancreatic ductal adenocarcinoma (PDAC), with PDAC patient-derived organoids serving as an ideal in vitro model for studying human cancers. The miRNA composition of EVs varies among patients, but there are common miRNA sets in matched organoids and blood plasma samples. Levels of miR-21 and miR-195 in PDAC blood EVs are elevated compared to healthy controls, suggesting a potential biomarker for the disease.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Add to Collection

Article Oncology

Liquid biopsy enters the clinic - implementation issues and future challenges

Michail Ignatiadis et al.

Summary: The approval of liquid biopsy assays for detecting genetic alterations in plasma cell-free DNA has marked a tipping point for the clinical use of this technology, especially in patients with advanced-stage cancer. The next frontier is likely to be the systemic treatment of patients with 'ctDNA relapse' and other potential future applications include cancer screening and diagnosis.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Patient-Derived Tumor Chemosensitization of GKB202, an Antrodia Cinnamomea Mycelium-Derived Bioactive Compound

Tsung-Ju Li et al.

Summary: A new method for cultivating CTC was developed to test the bioactive compounds from Antrodia Cinnamomea. Experimental results showed that a compound called GKB202 exhibited significant cytotoxic and sensitizing effects to 5-FU on 8 different tumor sources. Animal studies indicated rapid clearance and good tolerance of GKB202 in the liver at a dose of 20 mg/kg.

MOLECULES (2021)

Add to Collection

Article Multidisciplinary Sciences

Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer

Maximilian W. Schenk et al.

Summary: In small cell lung cancer, acquired resistance to standard platinum-etoposide chemotherapy often occurs, with Notch and nitric oxide pathways playing a role in mediating this resistance. Upregulation of soluble guanylate cyclase in residual tumor cells is associated with chemoresistance, highlighting this pathway as a potential target for treating relapsed SCLC.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Human retinal organoids release extracellular vesicles that regulate gene expression in target human retinal progenitor cells

Jing Zhou et al.

Summary: Research has shown that three-dimensional retinal tissue derived from human induced pluripotent stem cells release exosomes and microvesicles containing small noncoding RNA cargo. The miRNA cargo of these EVs correlates with Gene Ontology pathways relevant to specific developmental stages of human retina development.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Oncology

Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck Cancer

Kuan-Chou Lin et al.

Summary: This study introduces a novel strategy to predict clinical drug responses in HNC patients by using eSelect, a lab-developed biomimetic cell culture system, allowing for ex vivo expansion and drug sensitivity profiling of circulating tumor cells (CTCs). Results show that the cisplatin sensitivity profiles of patient-derived CTCs expanded ex vivo correlate with a clinical response to cisplatin treatment, potentially providing predictive assays to guide HNC treatments.

CANCERS (2021)

Add to Collection

Article Hematology

Rational biomarker development for the early and minimally invasive monitoring of AML

Sherif Abdelhamed et al.

Summary: Recurrent disease in acute myeloid leukemia (AML) is a major cause of treatment failure across age groups. Current monitoring of relapse risk and disease burden in AML patients is challenging due to the late appearance of symptoms. This study identified a set of unique circulating miRNA in AML-derived vesicles in peripheral blood, showing promise as a potential minimally invasive biomarker for AML.

BLOOD ADVANCES (2021)

Add to Collection

Article Gastroenterology & Hepatology

Liquid Biopsy for Colorectal Adenoma: Is the Exosomal miRNA Derived From Organoid a Potential Diagnostic Biomarker?

Tomoyuki Handa et al.

Summary: Exosomal miRNAs derived from CRA organoid culture could be potential diagnostic biomarkers for CRA.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2021)

Add to Collection

Article Oncology

A Novel, Personalized Drug-Screening System for Platinum-Resistant Ovarian Cancer Patients: A Preliminary Clinical Report

Yunke Huang et al.

Summary: This study established a personalized and sensitive drug-screening system for platinum-resistant ovarian cancer patients, identifying potentially effective drugs for the patients using mini-PDX models. The clinical-benefit rate was 75.0%, demonstrating the efficacy of the personalized drug-selection system.

CANCER MANAGEMENT AND RESEARCH (2021)

Add to Collection

Article Medicine, Research & Experimental

Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients

Florent Mouliere et al.

Summary: The study focused on detecting glioma-derived cell-free DNA (cfDNA) in body fluids and found that tumor-derived DNA could be identified in the majority of CSF, plasma, and urine samples with different tumor fractions. They also discovered a significant difference in cfDNA fragment sizes between glioma patients and individuals with non-malignant brain disorders or healthy individuals, which could potentially aid in non-invasive cancer detection using machine learning models.

EMBO MOLECULAR MEDICINE (2021)

Add to Collection

Article Oncology

Generating human prostate cancer organoids from leukapheresis enriched circulating tumour cells

Lisanne Mout et al.

Summary: DLA is an efficient method to enrich CTCs from patients with mPCa, providing a rich source of viable tumour cells despite the modest success rate in culturing CTCs. Organoid cultures had a success rate of 35%, with significantly higher CTC numbers in successful cultures.

EUROPEAN JOURNAL OF CANCER (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Extracellular Vesicles as a Therapeutic Tool for Kidney Disease: Current Advances and Perspectives

Raphael Rodrigues Correa et al.

Summary: Extracellular vesicles derived from stem cells in the kidneys have shown promising potential for tissue recovery, but face challenges such as the need for a high quantity of EVs, optimization of isolation and characterization techniques, as well as the requirement for a heterogeneous group of molecules. Recent advances in technologies like bioreactors and microfluidics have been explored to improve EVs' efficacy, aiming at their clinical applications for kidney diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Article Multidisciplinary Sciences

Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden

Peter Peneder et al.

Summary: The study introduces an integrated genetic/epigenetic analysis method for liquid biopsy of pediatric tumors with few genetic aberrations. The LIQUORICE algorithm is developed for detecting and classifying circulating tumor DNA based on cancer-specific chromatin signatures. The research highlights the potential value of cfDNA fragmentation patterns as prognostic biomarkers in Ewing sarcoma and makes liquid biopsy benefits more accessible for childhood cancers.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer

Rokana Taftaf et al.

Summary: CTC clusters are more efficient in mediating metastasis and ICAM1 may be a novel therapeutic target for the initiation of TNBC metastasis.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Cell Biology

Wnt Activity and Cell Proliferation Are Coupled to Extracellular Vesicle Release in Multiple Organoid Models

Gyongyver Orsolya Sandor et al.

Summary: The study revealed a connection between cell proliferation rate and EV release, which could be blocked by Wnt secretion inhibitors. LUAD cells marked by CD133 exhibit malignant behavior.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Review Oncology

Better together: circulating tumor cell clustering in metastatic cancer

Emma Schuster et al.

Summary: CTC clusters play a crucial role in cancer, with a higher metastatic potential and unfavorable clinical outcomes compared to single CTCs. While the mechanism of CTC cluster formation is still unclear, certain cell adhesion molecules and tight junction proteins have been identified as key factors.

TRENDS IN CANCER (2021)

Add to Collection

Article Medicine, Research & Experimental

EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer

Xia Liu et al.

Summary: Research has shown that inhibiting EGFR can block the circulating cancer stem cell (cCSC) clustering and lung metastasis of triple-negative breast cancer (TNBC). In addition to CD44, microRNA-30c also plays a negative regulatory role in cCSC clustering and lung metastasis.

THERANOSTICS (2021)

Add to Collection

Article Medicine, Research & Experimental

Transplantation of autologous extracellular vesicles for cancer-specific targeting

Alessandro Villa et al.

Summary: Research has shown that nano- and microsized extracellular vesicles (EVs) play a significant role in intercellular communication and can be used for targeted cancer therapy. By labeling EVs with indocyanine green (ICG) and tracking their distribution, it was found that nanoparticles with cancer tropism exist in the blood of colorectal cancer (CRC) patients. In mouse models, it was demonstrated that transplanted EVs were able to recognize tumors and deliver tumor-interfering molecules, indicating the therapeutic potential of autologous EVs for cancer treatment.

THERANOSTICS (2021)

Add to Collection

Article Oncology

Metastatic seeding of human colon cancer cell clusters expressing the hybrid epithelial/mesenchymal state

Kosuke Mizukoshi et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Add to Collection

Article Oncology

Tumor shedding and metastatic progression after tumor excision in patient-derived orthotopic xenograft models of triple-negative breast cancer

Aryana M. Razmara et al.

CLINICAL & EXPERIMENTAL METASTASIS (2020)

Add to Collection

Review Gastroenterology & Hepatology

Utility of Liquid Biopsy Analysis in Detection of Hepatocellular Carcinoma, Determination of Prognosis, and Disease Monitoring: A Systematic Review

Vincent L. Chen et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Genetic characterization of a unique neuroendocrine transdifferentiation prostate circulating tumor cell-derived eXplant model

Vincent Faugeroux et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Medicine, Research & Experimental

Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology

Zahra Dantes et al.

JCI INSIGHT (2020)

Add to Collection

Article Oncology

The Rare YAP1 Subtype of SCLC Revisited in a Biobank of 39 Circulating Tumor Cell Patient Derived Explant Models: A Brief Report

Sarah M. Pearsall et al.

JOURNAL OF THORACIC ONCOLOGY (2020)

Add to Collection

Article Oncology

Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells

Spas Dimitrov-Markov et al.

MOLECULAR CANCER THERAPEUTICS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma

Beng Yang et al.

ONCOGENE (2020)

Add to Collection

Article Medicine, Research & Experimental

PDX-derived organoids model in vivo drug response and secrete biomarkers

Ling Huang et al.

JCI INSIGHT (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Breast cancer organoid model allowed to reveal potentially beneficial combinations of 3,3′-diindolylmethane and chemotherapy drugs

Sergey V. Nikulin et al.

BIOCHIMIE (2020)

Add to Collection

Article Oncology

Brief report on the clinical characteristics of patients whose samples generate small cell lung cancer circulating tumour cell derived explants

Alexander J. Vickers et al.

LUNG CANCER (2020)

Add to Collection

Article Oncology

Ex Vivo Expansion and Drug Sensitivity Profiling of Circulating Tumor Cells from Patients with Small Cell Lung Cancer

Hsin-Lun Lee et al.

CANCERS (2020)

Add to Collection

Article Oncology

A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity

Kathryn L. Simpson et al.

NATURE CANCER (2020)

Add to Collection

Article Oncology

Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer

C. Allison Stewart et al.

NATURE CANCER (2020)

Add to Collection

Article Oncology

Establishment and characterization of a patient-derived circulating lung tumor cell line in vitro and in vivo

Zujun Que et al.

CANCER CELL INTERNATIONAL (2019)

Add to Collection

Review Oncology

The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper

Massimo Cristofanilli et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

Neutrophils escort circulating tumour cells to enable cell cycle progression

Barbara Maria Szczerba et al.

NATURE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

N-Glycoproteomics of Patient-Derived Xenografts: A Strategy to Discover Tumor-Associated Proteins in High-Grade Serous Ovarian Cancer

Ankit Sinha et al.

CELL SYSTEMS (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Extracellular vesicle release from intestinal organoids is modulated by Apc mutation and other colorectal cancer progression factors

Zsuzsanna Szvicsek et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2019)

Add to Collection

Article Oncology

Human-specific RNA analysis shows uncoupled epithelial-mesenchymal plasticity in circulating and disseminated tumour cells from human breast cancer xenografts

Anthony Tachtsidis et al.

CLINICAL & EXPERIMENTAL METASTASIS (2019)

Add to Collection

Article Oncology

The identification of a TNBC liver metastasis gene signature by sequential CTC-xenograft modeling

Monika Vishnoi et al.

MOLECULAR ONCOLOGY (2019)

Add to Collection

Review Cell Biology

CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs)

Tala Tayoun et al.

CELLS (2019)

Add to Collection

Article Multidisciplinary Sciences

Identification of Circulating Serum Multi-MicroRNA Signatures in Human DLBCL Models

Afshin Beheshti et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Medicine, General & Internal

A CTC-Cluster-Specific Signature Derived from OMICS Analysis of Patient-Derived Xenograft Tumors Predicts Outcomes in Basal-Like Breast Cancer

Hariprasad Thangavel et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Add to Collection

Article Oncology

Measurement of Plasma Cell-Free Mitochondrial Tumor DNA Improves Detection of Glioblastoma in Patient-Derived Orthotopic Xenograft Models

Richard Mair et al.

CANCER RESEARCH (2019)

Add to Collection

Article Oncology

Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models

Xia Liu et al.

CANCER DISCOVERY (2019)

Add to Collection

Article Genetics & Heredity

Ultra-Sensitive Automated Profiling of EpCAM Expression on Tumor-Derived Extracellular Vesicles

Pouya Amrollahi et al.

FRONTIERS IN GENETICS (2019)

Add to Collection

Article Oncology

Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer

Vishnu C. Ramani et al.

BREAST CANCER RESEARCH (2019)

Add to Collection

Review Oncology

Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

Charles M. Rudin et al.

NATURE REVIEWS CANCER (2019)

Add to Collection

Article Oncology

Targeting USP7 Identifies a Metastasis-Competent State within Bone Marrow-Resident Melanoma CTCs

Monika Vishnoi et al.

CANCER RESEARCH (2018)

Add to Collection

Article Oncology

The Combination of the PARP Inhibitor Olaparib and the WEE1 Inhibitor AZD1775 as a New Therapeutic Option for Small Cell Lung Cancer

Alice Lallo et al.

CLINICAL CANCER RESEARCH (2018)

Add to Collection

Article Oncology

Circulating Tumor Cell Number as a Response Measure of Prolonged Survival for Metastatic Castration-Resistant Prostate Cancer: A Comparison With Prostate-Specific Antigen Across Five Randomized Phase III Clinical Trials

Glenn Heller et al.

JOURNAL OF CLINICAL ONCOLOGY (2018)

Add to Collection

Review Cell Biology

Shedding light on the cell biology of extracellular vesicles

Guillaume van Niel et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Add to Collection

Article Oncology

Genomic and Functional Fidelity of Small Cell Lung Cancer Patient-Derived Xenografts

Benjamin J. Drapkin et al.

CANCER DISCOVERY (2018)

Add to Collection

Article Oncology

Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer

Chelain R. Goodman et al.

JAMA ONCOLOGY (2018)

Add to Collection

Article Oncology

Variants With a Low Allele Frequency Detected in Genomic DNA Affect the Accuracy of Mutation Detection in Cell-Free DNA by Next-Generation Sequencing

Jacqueline F. Wang et al.

CANCER (2018)

Add to Collection

Article Oncology

Identifying biomarkers of breast cancer micrometastatic disease in bone marrow using a patient-derived xenograft mouse model

Sreeraj G. Pillai et al.

BREAST CANCER RESEARCH (2018)

Add to Collection

Article Oncology

Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutation

Hongjuan Zhao et al.

CANCER BIOLOGY & THERAPY (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancer

Louise Carter et al.

NATURE MEDICINE (2017)

Add to Collection

Article Oncology

Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients

J. Vidal et al.

ANNALS OF ONCOLOGY (2017)

Add to Collection

Article Oncology

Development of a circulating miRNA assay to monitor tumor burden: From mouse to man

Alastair Greystoke et al.

MOLECULAR ONCOLOGY (2016)

Add to Collection

Article Oncology

Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma

Maria Romina Girotti et al.

CANCER DISCOVERY (2016)

Add to Collection

Article Oncology

Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study

C. J. Morrow et al.

ANNALS OF ONCOLOGY (2016)

Add to Collection

Article Oncology

Highly Personalized Detection of Minimal Ewing Sarcoma Disease Burden From Plasma Tumor DNA

Masanori Hayashi et al.

CANCER (2016)

Add to Collection

Article Oncology

Inhibition of PI3K/BMX Cell Survival Pathway Sensitizes to BH3 Mimetics in SCLC

Danielle S. Potter et al.

MOLECULAR CANCER THERAPEUTICS (2016)

Add to Collection

Review Multidisciplinary Sciences

Metastatic colonization by circulating tumour cells

Joan Massague et al.

NATURE (2016)

Add to Collection

Article Biochemistry & Molecular Biology

Patient-derived induced pluripotent stem cells in cancer research and precision oncology

Eirini P. Papapetrou

NATURE MEDICINE (2016)

Add to Collection

Article Multidisciplinary Sciences

Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters

Kevin J. Cheung et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Add to Collection

Article Multidisciplinary Sciences

Vasculogenic mimicry in small cell lung cancer

Stuart C. Williamson et al.

NATURE COMMUNICATIONS (2016)

Add to Collection

Article Multidisciplinary Sciences

Binary colloidal crystals (BCCs) as a feeder-free system to generate human induced pluripotent stem cells (hiPSCs)

Peng-Yuan Wang et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Article Oncology

p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer

Emily Powell et al.

BREAST CANCER RESEARCH (2016)

Add to Collection

Article Oncology

Plasma exosome microRNAs are indicative of breast cancer

Bethany N. Hannafon et al.

BREAST CANCER RESEARCH (2016)

Add to Collection

Article Oncology

High tumor budding stratifies breast cancer with metastatic properties

Bodour Salhia et al.

BREAST CANCER RESEARCH AND TREATMENT (2015)

Add to Collection

Article Oncology

Establishment and Characterization of a Cell Line from Human Circulating Colon Cancer Cells

Laure Cayrefourcq et al.

CANCER RESEARCH (2015)

Add to Collection

Review Oncology

Exosomes in cancer: small particle, big player

Xu Zhang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)

Add to Collection

Article Multidisciplinary Sciences

Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells

Devon A. Lawson et al.

NATURE (2015)

Add to Collection

Review Oncology

Examining the utility of patient-derived xenograft mouse models

Samuel Aparicio et al.

NATURE REVIEWS CANCER (2015)

Add to Collection

Article Oncology

Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis

Mario Giuliano et al.

BREAST CANCER RESEARCH (2015)

Add to Collection

Article Biochemistry & Molecular Biology

Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis

Nicola Aceto et al.

CELL (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Dong Gao et al.

CELL (2014)

Add to Collection

Article Biochemistry & Molecular Biology

Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer

Cassandra L. Hodgkinson et al.

NATURE MEDICINE (2014)

Add to Collection

Article Oncology

Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model

Zhuo Zhang et al.

ONCOTARGET (2014)

Add to Collection

Article Gastroenterology & Hepatology

Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection

Yun-Fan Sun et al.

HEPATOLOGY (2013)

Add to Collection

Article Biotechnology & Applied Microbiology

Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

Irene Baccelli et al.

NATURE BIOTECHNOLOGY (2013)

Add to Collection

Article Genetics & Heredity

Emerging landscape of oncogenic signatures across human cancers

Giovanni Ciriello et al.

NATURE GENETICS (2013)

Add to Collection

Article Cell Biology

The Identification and Characterization of Breast Cancer CTCs Competent for Brain Metastasis

Lixin Zhang et al.

SCIENCE TRANSLATIONAL MEDICINE (2013)

Add to Collection

Article Oncology

Amplification of the MET Receptor Drives Resistance to Anti-EGFR Therapies in Colorectal Cancer

Alberto Bardelli et al.

CANCER DISCOVERY (2013)

Add to Collection

Article Oncology

Monitoring serial changes in circulating human breast cancer cells in murine xenograft models

Jean-Pierre Eliane et al.

CANCER RESEARCH (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.